Category: FDA

March 26, 2012

Bergeson & Campbell, P.C. Adds Senior Government Affairs Counsel, John H. Thorne, Ph.D., to Its Public Policy Practice

Bergeson & Campbell, P.C. and its consulting affiliates, B&C Consortia Management, L.L.C. (BCCM) and The Acta Group, L.L.C. (Acta), are pleased to announce that John H. Thorne, Ph.D., has joined our public policy practice as Senior Government Affairs Counsel for B&C and Vice President of Policy and Government Affairs for Acta. Dr. Thorne is a leader in the areas of agricultural and pesticide industries, and brings extensive experience with related regulatory, legislative, and policy...
January 11, 2012

Lynn L. Bergeson, “FDA’s Regulation of Nanotechnology: Will the New Draft Guidance Help Industry?,” Nanotechnology Law & Business, Volume 8, Issue 3.

The U.S. Food and Drug Administration's (FDA) approach to nanotechnology is the subject of intense interest for at least three reasons. First, many promising and visible applications of nano-technology include cosmetics, sunscreens, pharmaceuticals, dietary supplements, and medical devices. These products are subject to FDA jurisdiction under the Federal Food, Drug, and Cosmetic Act (FFDCA). Second, FDA faces unique challenges in regulating products of nanotechnology be-cause of the...
January 7, 2012

Lynn L. Bergeson, “Topical Briefing on recent Lawsuit filed against US FDA,” Nanotechnology Industries Association Newsletter, January 7, 2012.

On the 21st of December 2011, a U.S. coalition of nonprofit consumer safety and environmental groups filed a lawsuit against the U.S. Food and Drug Administration (FDA) for alleged failure to regulate what the coalition deems health and environmental risks stemming from nanotechnology-enabled products put on the market. The coalition was led by the International Center for Technology Assessment (ICTA) and represents the following plaintiffs: Friends of the Earth, Food and Water Watch, the Center...
January 7, 2012

Lynn L. Bergeson, “Topical Briefing on recent Lawsuit filed against US FDA,” Nanotechnology Industries Association Newsletter, January 7, 2012.

On the 21st of December 2011, a U.S. coalition of nonprofit consumer safety and environmental groups filed a lawsuit against the U.S. Food and Drug Administration (FDA) for alleged failure to regulate what the coalition deems health and environmental risks stemming from nanotechnology-enabled products put on the market. The coalition was led by the International Center for Technology Assessment (ICTA) and represents the following plaintiffs: Friends of the Earth, Food and Water Watch, the Center...
January 3, 2012

Predictions for EPA’s Office of Chemical Safety and Pollution Prevention, and Beyond

Bergeson & Campbell, P.C.'s (B&C) thoughts are below on what may be headed our way in 2012 from the U.S. Environmental Protection Agency's (EPA) Office of Chemical Safety and Pollution Prevention (OCSPP). The 2012 Presidential Election cycle will influence any activity by either party or the Administration over the next year. We also offer a few thoughts on Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), the Food and Drug Administration (FDA), and Asian...
December 29, 2011

Coalition Sues FDA Over Alleged Risks from Nanotechnology and Nanomaterials

A coalition of nonprofit consumer safety and environmental groups sued the Food and Drug Administration (FDA) in the U.S. District Court for the Northern District of California on December 21, 2011.  The coalition is led by the International Center for Technology Assessment (ICTA), and includes Friends of the Earth, Food and Water Watch, the Center for Environmental Health, the ETC Group, and the Institute for Agricultural and Trade Policy. ICTA states that its lawsuit “demands” FDA...
November 9, 2011

Small Bites, Bigger Questions

The November 9, 2011, issue of New Haven Independent quotes Lynn L. Bergeson regarding the Food and Drug Administration’s (FDA) regulation of nanotechnology.
October 17, 2011

Lynn L. Bergeson Will Speak During the NanoEHS Workshop Series Webinar

Bergeson & Campbell, P.C. (B&C), B&C Consortia Management, L.L.C. (BCCM), The Acta Group, L.L.C. (Acta), and The Acta Group EU, Ltd (Acta EU) are pleased to announce that on October 20, 2011, from 12:00 p.m. to 12:45 p.m. (EDT), Lynn L. Bergeson will speak during the nanoEHS Workshop Series webinar hosted by the National Nanotechnology Initiative (NNI) on the release of its 2011 Environmental, Health, and Safety Research Strategy (Strategy). The event will consist of...
October 11, 2011

Nanotechnology Regulatory Science Act of 2011 Introduced in Senate

On October 6, 2011, Senator Mark L. Pryor (D-AR) introduced the Nanotechnology Regulatory Science Act of 2011 (S. 1662), which is intended to address potential health and safety risks from products that contain nanotechnology materials. The bill would establish a program within the U.S. Food and Drug Administration (FDA) to assess the health and safety implications of using nanotechnology in everyday products and develop best practices for companies using nanotechnology. The legislation would...
September 7, 2011

B&C Launches Newly Redesigned Website

Bergeson & Campbell, P.C. (B&C) is pleased to announce the launch of our newly redesigned website, which has been streamlined to make it easier to navigate. The substantive and timely legal and regulatory information we provide remains available. This information covers a wide range of topics, including the Toxic Substances Control Act (TSCA), nanotechnology, the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), Green Chemistry, the Food and Drug Administration (FDA), the...